Our previous study demonstrated that IFNβ extended tPA therapeutic window to 3h post-injury in ischemic stroke in which IFNβ ameliorated delayed tPA-exacerbated ischemic brain injury and lessened tPA-aggravated BBB disruption and HT (20). The gene discussed is IFNB1; the disease is brain injury.